Global first for Salford team in rare disease study

Press/Media: Research


Congratulations to the Salford Royal Core Research Team, Professor Hector Chinoy (PI) and Dr James Lilleker for dosing the first patient globally in a study testing the efficacy and safety of a new treatment for a rare inflammatory muscle disease.

Period4 Dec 2019 → 9 Jan 2020

Media coverage


Media coverage